Updated analysis from KEYNOTE-189: pembrolizumab or placebo plus pemetrexed and platinum for previously untreated metastatic nonsquamous non-small-cell lung cancer - Gadgeel, Shirish; Rodríguez-Abreu, Delvys; Speranza, Giovanna; Esteban, Emilio; Felip, Enriqueta; Dómine, Manuel; Hui, Rina; Hochmair, Maximilian J.; Clingan, Philip; Powell, Steven F.; Cheng, Susanna Yee-Shan; Bischoff, Helge; et al. (Journal of clinical oncology, 2020)
Gesehen am 06.05.2021